Published in Health Policy on August 04, 2010
The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J (2013) 1.50
Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul - Turkey. Pharm Pract (Granada) (2012) 1.11
What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med (2015) 1.02
Commentary: Patient Cost Sharing and Medical Expenditures for the Elderly. Front Pharmacol (2016) 0.88
Demonstrating Value for Biosimilars: A Conceptual Framework. Am Health Drug Benefits (2015) 0.87
Community pharmacists' attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan. J Pharm Policy Pract (2015) 0.77
Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society. Int J Clin Pharm (2014) 0.76
[Generic drug in Morocco: the point of view of the consumer]. Pan Afr Med J (2013) 0.76
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open (2015) 0.76
Patients' beliefs about generic medicines in Malaysia. Pharm Pract (Granada) (2014) 0.76
Use of generic medicines by the Brazilian population: an evaluation of PNAUM 2014. Rev Saude Publica (2016) 0.75
The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort study. BMC Health Serv Res (2015) 0.75
Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city. Rev Saude Publica (2017) 0.75
Stereoselective transport of histidine in rat lung microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol (2002) 1.40
Acute nephrotoxicity of aristolochic acids in mice. J Pharm Pharmacol (2004) 1.12
Selective toxicity of aristolochic acids I and II. Drug Metab Dispos (2007) 1.11
Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun (2003) 1.02
Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology (2010) 1.02
Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol (2009) 0.99
Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke (2005) 0.99
A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy. Drug Metab Pharmacokinet (2004) 0.99
Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines. Int J Oncol (2011) 0.93
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regul Pept (2010) 0.91
Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis (2008) 0.90
Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. J Am Soc Nephrol (2010) 0.90
Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J (2002) 0.90
Predominant role of FcgammaRIII in the induction of accelerated nephrotoxic glomerulonephritis. Kidney Int (2003) 0.88
Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab Res Rev (2006) 0.88
Halofuginone prevents extracellular matrix deposition in diabetic nephropathy. Biochem Biophys Res Commun (2008) 0.85
Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection. Nephron Exp Nephrol (2009) 0.83
Induction of nephrotoxic serum nephritis in inbred mice and suppressive effect of colchicine on the development of this nephritis. Pharmacol Res (2002) 0.82
An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice. Exp Diabetes Res (2012) 0.82
Increased expression of long pentraxin PTX3 in inflammatory bowel diseases. Dig Dis Sci (2007) 0.81
Interactions of human organic anion transporters with aristolochic acids. J Pharmacol Sci (2010) 0.80
Public involvement in pharmacogenomics research: a national survey on public attitudes towards pharmacogenomics research and the willingness to donate DNA samples to a DNA bank in Japan. Cell Tissue Bank (2009) 0.80
Doubling of serum creatinine: is it appropriate as the endpoint for CKD? Proposal of a new surrogate endpoint based on the reciprocal of serum creatinine. Clin Exp Nephrol (2010) 0.79
Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice. Clin Immunol (2002) 0.79
[Change in function of gastric acid secretion by aging]. Nihon Rinsho (2010) 0.78
Possible impact of nitric oxide on the antihypertensive effect of captopril and zaprinast. Adv Ther (2003) 0.78
Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain. Am J Hosp Palliat Care (2012) 0.78
Apelin-12 stimulates acid secretion through an increase of histamine release in rat stomachs. Regul Pept (2011) 0.78
Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. Neurotoxicology (2004) 0.78
Public involvement in pharmacogenomics research: a national survey on patients' attitudes towards pharmacogenomics research and the willingness to donate DNA samples to a DNA bank in Japan. Cell Tissue Bank (2009) 0.78
Effect of diabetes on aortic nitric oxide synthesis in spontaneously hypertensive rats; does captopril modulate this effect? Life Sci (2005) 0.78
Phthalocyanine-based fluorescence probes for detecting ascorbic acid: phthalocyaninatosilicon covalently linked to TEMPO radicals. Chem Commun (Camb) (2011) 0.77
Developing and integrating an adverse drug reaction reporting system with the hospital information system. Yakugaku Zasshi (2002) 0.77
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial. Clin Exp Nephrol (2013) 0.77
Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives. Neurotoxicology (2004) 0.77
Prediction of iopromide reduction rates during haemodialysis using an in vitro dialysis system. Nephrol Dial Transplant (2005) 0.75
[Diagnosis of drug induced nephropathy]. Nihon Jinzo Gakkai Shi (2012) 0.75
[Pilot study of the practical use of Internet in medical services: the questionnaire for pharmacists in Japan]. Yakugaku Zasshi (2002) 0.75
[A case of membranous nephropathy with ANCA-associated necrotizing glomerulonephritis during oral administration of PTU for Graves' disease]. Nihon Jinzo Gakkai Shi (2003) 0.75
Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients. Pharm World Sci (2010) 0.75
[Case report summary browsing system for education of pharmaceutical students through the Internet]. Yakugaku Zasshi (2002) 0.75
Regulation of the statements in the information on drug metabolizing enzyme in the package insert--the present regulation and its history in Japan, the U.S. and the U.K. Yakushigaku Zasshi (2008) 0.75
[Safe and successful chemoradiotherapy for a patient with cardiac pacemaker and triple cancers]. Gan To Kagaku Ryoho (2009) 0.75
[Retardation of hemodialysis by recombinant human erythropoietin in patients with chronic kidney disease]. Nihon Jinzo Gakkai Shi (2010) 0.75